Sentences with phrase «economic exposure to the company»

Not exact matches

Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost of accommodating, announced increases in the build rates of certain aircraft; 6) the effect on aircraft demand and build rates of changing customer preferences for business aircraft, including the effect of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result of global economic uncertainty or otherwise; 8) the effect of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution of key milestones such as the receipt of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation of our announced acquisition of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect of changes in tax law, such as the effect of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability of raw materials and purchased components; 23) our ability to recruit and retain a critical mass of highly - skilled employees and our relationships with the unions representing many of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment of interest on, and principal of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness of any interest rate hedging programs; 28) the effectiveness of our internal control over financial reporting; 29) the outcome or impact of ongoing or future litigation, claims, and regulatory actions; 30) exposure to potential product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks of doing business internationally, including fluctuations in foreign current exchange rates, impositions of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.

American companies also have relatively little exposure to European economic weakness.

In such situations, we are finding companies we regard as extremely well run, growing at a fast pace, and providing exposure to key themes such as economic growth, demographic changes, and local consumer trends.

Investors in Vanguard S&P 500 ETF are getting exposure to 500 of the biggest and most successful businesses of our time, and chances are that these companies as a group will continue producing growing earnings and cash flows for investors over the coming decades, no matter how tough the economic environment in the short term.

Included in such funds are the kinds of companies I discussed in an article about stocks Warren Buffett might buy; stocks with wide moats, strong financial positions, and product lines that sell just as well in recession as they do in periods of strong economic growth.A low volatility ETF is an easy way to get exposure to stock - like returns without the crazy up and downs.

By adopting a global perspective, investors gain access to a larger pool of potentially great companies, more direct exposure to economic growth potential outside the U.S., the potential for exposure to less - covered (and therefore potentially more undervalued) companies, and the demonstrable diversification effects created by currency exposure (as well as the natural gives and takes of economic activity around the globe).

Adopting the discipline of rebalancing bond exposures toward fundamental weights, which are linked to the economic size of the underlying issuing companies rather than to the amount of debt they have issued, achieves the dual objective of: 1) tilting holdings toward companies with better debt servicing and higher credit ratings; and 2) taking advantage of mean reversion in securities prices over time.

And so, accordingly, it tends to attract pretty dissimilar investor constituencies, who may only focus on: i) a handful of the largest caps, regardless of valuation & exposure, ii) stocks which (may) offer cheap / alternative access to overseas growth (a surprisingly large number of Irish companies are UK / Europe / globally focused), iii) stocks offering domestic exposure (notably, economic pure - plays are actually pretty rare), iv) a listed commercial & residential property sector that's only emerged in the past couple of years, and finally (& perhaps most notoriously) v) a (junior) resource stock sector that's been decimated in the last few years.

However, insurance companies also offer the same exposure to every economic nook & cranny, minus the obscene leverage!

Risks and uncertainties include but are not limited to, general industry conditions and competition; general economic factors, including interest rate and currency exchange rate fluctuations; the impact of pharmaceutical industry regulation and health care legislation in the United States and internationally; global trends toward health care cost containment; technological advances, new products and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approval; the company's ability to accurately predict future market conditions; manufacturing difficulties or delays; financial instability of international economies and sovereign risk; dependence on the effectiveness of the company's patents and other protections for innovative products; and the exposure to litigation, including patent litigation, and / or regulatory actions.

His role will be to get companies to reveal more information about their exposure to extreme weather impacts, climate lawsuits and a clean economic shift.

For fossil fuel companies, disclosure of Scope 1 and 2 emissions does not provide the market with a useful indication of their exposure or adaptation to particular climate - related financial risks as the primary risks are to the economic viability of existing reserves and future development projects that might add to that reserve base.

As part of her extensive multinational practice, Giovanna also handles transfer pricing matters for Fortune 50 companies and foreign - owned clients, working closely with economic experts in tax planning to establish cost sharing and related party licensing arrangements; assess multijurisdictional transfer pricing exposure; comply with FIN 48 and return documentation requirements; and develop audit, litigation, advance pricing agreement and authority strategies.

We have successfully defended many of the world's largest companies in cases involving catastrophic bodily injury, property damage or economic loss allegedly caused by defective products and devices or exposure to toxic substances.

For our clients based in Cleveland, Ohio, we serve as a conduit into the city's dominant economic industries, providing companies with exposure to top executive candidates in highly specialized sectors like diversified manufacturing, rail, real estate, engineering, information technology, science, and research.